Shares of Adtalem Global Education Inc. (NYSE:CVSA – Get Free Report) have been assigned an average rating of “Hold” from the five research firms that are presently covering the stock, Marketbeat.com reports. Three research analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average 1 year target price among brokers that have issued a report on the stock in the last year is $151.67.
Several analysts recently issued reports on the stock. Weiss Ratings raised shares of Adtalem Global Education from a “hold (c)” rating to a “hold (c+)” rating in a report on Wednesday, October 21st. BMO Capital Markets dropped their target price on shares of Adtalem Global Education from $148.00 to $145.00 and set an “outperform” rating on the stock in a report on Monday, October 5th. Truist Financial downgraded shares of Adtalem Global Education from a “buy” rating to a “hold” rating and set a $140.00 target price on the stock. in a report on Thursday, September 3rd. Finally, Wall Street Zen raised shares of Adtalem Global Education from a “hold” rating to a “buy” rating in a research report on Sunday, September 27th.
View Our Latest Research Report on CVSA
Insiders Place Their Bets
In related news, SVP Douglas Beck sold 4,526 shares of the business’s stock in a transaction dated Friday, August 7th. The stock was sold at an average price of $135.81, for a total transaction of $614,676.06. Following the completion of the transaction, the senior vice president owned 28,544 shares of the company’s stock, valued at approximately $3,876,560.64. The trade was a 13.69% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Robert Phelan sold 2,186 shares of the stock in a transaction that occurred on Friday, August 7th. The shares were sold at an average price of $135.15, for a total value of $295,437.90. Following the sale, the chief financial officer owned 48,306 shares of the company’s stock, valued at approximately $6,528,555.90. The trade was a 4.33% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 20,365 shares of company stock valued at $2,704,088. Company insiders own 2.70% of the company’s stock.
Institutional Investors Weigh In On Adtalem Global Education
An institutional investor recently bought a new position in Adtalem Global Education stock. Kendall Capital Management acquired a new position in Adtalem Global Education Inc. (NYSE:CVSA – Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 11,622 shares of the company’s stock, valued at approximately $1,449,000. Hedge funds and other institutional investors own 98.84% of the company’s stock.
Adtalem Global Education Stock Up 1.8%
CVSA opened at $128.77 on Friday. The firm has a market cap of $4.36 billion, a P/E ratio of 18.29, a price-to-earnings-growth ratio of 0.94 and a beta of 0.65. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.09 and a current ratio of 1.09. The business has a 50 day moving average price of $128.06 and a 200 day moving average price of $122.06. Adtalem Global Education has a twelve month low of $86.97 and a twelve month high of $145.43.
Adtalem Global Education (NYSE:CVSA – Get Free Report) last announced its quarterly earnings results on Thursday, October 29th. The company reported $2.19 EPS for the quarter, beating the consensus estimate of $1.90 by $0.29. Adtalem Global Education had a return on equity of 20.88% and a net margin of 12.87%. The company had revenue of $511.53 million for the quarter. Research analysts forecast that Adtalem Global Education will post 9.00 EPS for the current year.
About Adtalem Global Education
Adtalem Global Education, Inc is an education services company that provides healthcare and professional education through institutions serving students in the United States and internationally. The company focuses on preparing students for careers in healthcare, including nursing, medicine, veterinary medicine and other health-related fields.
Its portfolio has included Chamberlain University, Walden University, the American University of the Caribbean School of Medicine, Ross University School of Medicine and Ross University School of Veterinary Medicine.
Featured Stories
- Five stocks we like better than Adtalem Global Education
- Phillips 66 Posts Strong Earnings But the Stock Doesn’t Care
- NXP Semiconductors Falls After Strong Earnings—Is the Sell-Off Overdone?
- GE Vernova’s Reservations Are Turning Into Real Orders—But the Market Still Wants More.
- Where’s the Beef? Trian-Led Buyout Proposal Values Wendy’s at $1.4B, But Is It Enough?
Receive News & Ratings for Adtalem Global Education Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adtalem Global Education and related companies with MarketBeat.com's FREE daily email newsletter.
